Atnaujinta: 2024.07.04 10:08 (GMT+3)

Tallinna Farmaatsiatehas: Share issue

1999.08.10, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATISATEHAS
ANNOUNCEMENT
10.08.99

ISSUE OF TALLINNA FARMAATSIATEHASE AS SHARES

The Securities Inspectorate of the Republic of Estonia registered
on
10.08.99 the issue of 600 000 common shares of TFT AS.

Tallinna Farmaatsiatehase AS (Tondi 33, Tallinn) announces that the
subscription period for Tallinna Farmaatsiatehas share issue will
begin
on Wednesday, 25.08.1999 and will end on 31.08.1999.

Tallinna Farmaatsiatehas will issue 600 000 nominal common shares
with
a face value and issue price of 10 EEK.

The subscription rights holders are entitled to subscribe for the
shares to be issued. Subscription rights belong to the shareholders
of
Tallinna Farmaatsiatehase AS, who are listed in the fixed list as
of
17.05.1999 at 08:00 a.m., in accordance with number of shares in
their
ownership as of 08:00 a.m. on 17.05.1999. Each share grants its
holder
the right to obtain one subscription right; seven subscription
rights
grant the right to obtain one share to be issued. The subscription
rights are freely transferable.

In order to subscribe for the shares to be issued, a person will
submit
the respective application via account operator of the Estonian
Central
Depository for Securities ("ECDS").
The account operators of the Estonian Central Depository for
Securities
are Eesti Krediidipank (address Narva St. 4, Tallinn); Eesti
Ühispank
(address Tornimäe 2, Tallinn); Hansapank (address Liivalaia St. 8,
Tallinn) and Optiva Pank (address Narva St. 11, Tallinn).

Payment deadline for shares to be issued is 15.09.1999.

The terms of the issue and the issue prospectus are available as of
11.08.99 at the headquarters of Tallinna Farmaatsiatehase AS (Tondi
33,
Tallinn).


Tallinna Farmaatsiatehase AS
Arno Kaseniit
Member of the Management Board
Tel +372 6 120 201

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai